(Q26738562)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27570127%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

review article

1 reference

title

Antiviral therapies on the horizon for influenza (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27570127%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27570127%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Annelies Stevaert

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27570127%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Evelien Vanderlinden

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27570127%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Annelies Stevaert

2

0 references

Evelien Vanderlinden

3

0 references

publication date

26 August 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27570127%20AND%20SRC:MED&resulttype=core&format=json

Current Opinion in Pharmacology

21 March 2020

published in

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27570127%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27570127%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

106-115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27570127%20AND%20SRC:MED&resulttype=core&format=json

Recent progress in designing inhibitors that target the drug-resistant M2 proton channels from the influenza A viruses.

21 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Emerging antiviral strategies to interfere with influenza virus entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

PA subunit of RNA polymerase as a promising target for anti-influenza virus agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Nitazoxanide: a first-in-class broad-spectrum antiviral agent

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Neuraminidase inhibitors: who, when, where?

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Influenza virus-host interactomes as a basis for antiviral drug development

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Influenza Polymerase Can Adopt an Alternative Configuration Involving a Radical Repacking of PB2 Domains

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Emerging antiviral targets for influenza A virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Crystallographic Fragment Screening and Structure-Based Optimization Yields a New Class of Influenza Endonuclease Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

The structural basis for an essential subunit interaction in influenza virus RNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Structure of influenza A polymerase bound to the viral RNA promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Structural insight into cap-snatching and RNA synthesis by influenza polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Crystal structure of the RNA-dependent RNA polymerase from influenza C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Identification of influenza A nucleoprotein as an antiviral target

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Generation and characterization of influenza A viruses with altered polymerase fidelity

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

The structural basis for cap binding by influenza virus polymerase subunit PB2

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

A broadly neutralizing human monoclonal antibody is effective against H7N9.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

The crystal structure of the PB2 cap-binding domain of influenza B virus reveals a novel cap recognition mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Molecular Basis of mRNA Cap Recognition by Influenza B Polymerase PB2 Subunit.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Preclinical pharmacokinetics of MHAA4549A, a human monoclonal antibody to influenza A virus, and the prediction of its efficacious clinical dose for the treatment of patients hospitalized with influenza A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Role of human hypoxanthine guanine phosphoribosyltransferase in activation of the antiviral agent T-705 (favipiravir)

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Highly Conserved Protective Epitopes on Influenza B Viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Mechanism of action of T-705 against influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Recognition of cap structure by influenza B virus RNA polymerase is less dependent on the methyl residue than recognition by influenza A virus polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Broadly neutralizing antiviral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Structural and Biochemical Basis for Development of Influenza Virus Inhibitors Targeting the PA Endonuclease

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

Structural Analysis of Specific Metal Chelating Inhibitor Binding to the Endonuclease Domain of Influenza pH1N1 (2009) Polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.COPH.2016.08.003

7 January 2021

10.1016/J.COPH.2016.08.003

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27570127%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference